| RS2041137663 |
PYCR1
|
Health Risk |
Likely pathogenic |
— |
| RS2041137887 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2041138210 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2041138762 |
FAH
|
Health Risk |
Pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2041140122 |
PYCR1
|
Health Risk |
Likely pathogenic |
PYCR1-related de Barsy syndrome, Autosomal recessive cutis laxa type 2B |
| RS2041140884 |
MAP2K2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiofaciocutaneous syndrome 4, RASopathy |
| RS2041142587 |
MAP2K2
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiofaciocutaneous syndrome 4 |
| RS2041143697 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2041147607 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2041149106 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS2041155203 |
FAH
|
Health Risk |
Likely pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2041155591 |
FAH
|
Health Risk |
Likely pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2041156486 |
FAH
|
Health Risk |
Likely pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2041157397 |
PYCR1
|
Health Risk |
Likely pathogenic |
Wiedemann-Rautenstrauch-like progeroid syndrome, Wiedemann-Rautenstrauch-like progeroid syndrome |
| RS2041157497 |
PYCR1
|
Health Risk |
Likely pathogenic |
Autosomal recessive cutis laxa type 2B, Autosomal recessive cutis laxa type 2B |
| RS2041199779 |
SLC12A1
|
Health Risk |
Likely pathogenic |
Bartter syndrome, Bartter syndrome |
| RS2041206341 |
SLC12A1
|
Health Risk |
Likely pathogenic |
— |
| RS2041207320 |
PYCR1
|
Health Risk |
Pathogenic |
Autosomal recessive cutis laxa type 2B, PYCR1- related autosomal recessive cutis laxa |
| RS2041210221 |
FAH
|
Health Risk |
Likely pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2041210282 |
FAH
|
Health Risk |
Pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2041230041 |
OCA2
|
Health Risk |
Pathogenic |
— |
| RS2041233118 |
OCA2
|
Health Risk |
Likely pathogenic |
Oculocutaneous albinism, Oculocutaneous albinism |
| RS2041233832 |
OCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tyrosinase-positive oculocutaneous albinism, Tyrosinase-positive oculocutaneous albinism |
| RS2041247681 |
FAH
|
Health Risk |
Pathogenic/Likely pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2041251614 |
CEP164
|
Health Risk |
Likely pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS2041254879 |
FAH
|
Health Risk |
Pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2041255686 |
FAH
|
Health Risk |
Likely pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2041269564 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 4 |
| RS2041270139 |
MYH11
|
Health Risk |
Likely pathogenic |
— |
| RS2041271232 |
FAH
|
Health Risk |
Pathogenic/Likely pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2041271608 |
FAH
|
Health Risk |
Pathogenic/Likely pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2041294652 |
FAH
|
Health Risk |
Likely pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2041303734 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2041306355 |
OCA2
|
Health Risk |
Likely pathogenic |
Tyrosinase-positive oculocutaneous albinism, Tyrosinase-positive oculocutaneous albinism |
| RS2041306808 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2041309291 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2041310524 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS2041311648 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS2041315307 |
SETD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2041316219 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2041316956 |
FAH
|
Health Risk |
Pathogenic/Likely pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2041318487 |
FAH
|
Health Risk |
Likely pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2041326700 |
FAH
|
Health Risk |
Pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2041368952 |
FAH
|
Health Risk |
Pathogenic/Likely pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2041370929 |
SETD5
|
Health Risk |
Likely pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2041376679 |
SETD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2041379399 |
SETD5
|
Health Risk |
Likely pathogenic |
— |
| RS2041379870 |
SETD5
|
Health Risk |
Likely pathogenic |
Chromatinopathy, Chromatinopathy |
| RS2041380175 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS2041416610 |
SETD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Luscan-Lumish syndrome, Inborn genetic diseases |
| RS2041433287 |
SETD2
|
Health Risk |
Pathogenic |
Luscan-Lumish syndrome, Thyroid cancer |
| RS2041472207 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Aortic aneurysm |
| RS2041490074 |
TMTC3
|
Health Risk |
Pathogenic |
Lissencephaly 8, Lissencephaly 8 |
| RS2041525028 |
OCA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Tyrosinase-positive oculocutaneous albinism, SKIN/HAIR/EYE PIGMENTATION 1 |
| RS2041526018 |
OCA2
|
Health Risk |
Pathogenic |
— |
| RS2041559629 |
SLC12A1
|
Health Risk |
Pathogenic |
— |
| RS2041597805 |
SGSH
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-A |
| RS2041613817 |
DMXL2
|
Health Risk |
Likely pathogenic |
— |
| RS2041614157 |
NALCN
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypotonia, infantile |
| RS2041615714 |
SGSH
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-A |
| RS2041622931 |
SGSH
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-A |
| RS2041634150 |
TRIP12
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2041642562 |
TRIP12
|
Health Risk |
Pathogenic |
Clark-Baraitser syndrome, Clark-Baraitser syndrome |
| RS2041650191 |
SLC12A1
|
Health Risk |
Likely pathogenic |
Bartter disease type 1, Bartter disease type 1 |
| RS2041679279 |
PIEZO2
|
Health Risk |
Likely pathogenic |
Gordon syndrome, Gordon syndrome |
| RS2041684401 |
PIBF1
|
Health Risk |
Likely pathogenic |
Joubert syndrome 33, Joubert syndrome 33 |
| RS2041696318 |
TRPM3
|
Health Risk |
Likely pathogenic |
— |
| RS2041698726 |
MAST3
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 108, Developmental and epileptic encephalopathy 108 |
| RS2041700760 |
CREB3L3
|
Health Risk |
Likely pathogenic |
— |
| RS2041729565 |
KDM6A
|
Health Risk |
Pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS2041767822 |
SLC25A38
|
Health Risk |
Pathogenic |
Sideroblastic anemia 2, Sideroblastic anemia 2 |
| RS2041767936 |
SLC25A38
|
Health Risk |
Pathogenic |
Sideroblastic anemia 2, Sideroblastic anemia 2 |
| RS2041768572 |
SLC25A38
|
Health Risk |
Pathogenic |
Sideroblastic anemia 2, Sideroblastic anemia 2 |
| RS2041772144 |
SGSH
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-A |
| RS2041773742 |
SLC25A38
|
Health Risk |
Pathogenic |
Sideroblastic anemia 2, Sideroblastic anemia 2 |
| RS2041774244 |
SGSH
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-A |
| RS2041797086 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Inborn genetic diseases |
| RS2041802189 |
POLE
|
Health Risk |
Likely pathogenic |
— |
| RS2041818115 |
SGSH
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-A |
| RS2041823623 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2041824025 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2041825246 |
POLE
|
Health Risk |
Pathogenic |
Intrauterine growth retardation, metaphyseal dysplasia |
| RS2041825753 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2041834385 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Intrauterine growth retardation, metaphyseal dysplasia |
| RS2041840084 |
SGSH
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-A |
| RS2041848486 |
ALDH1A3;ALDH1A3-AS1
|
Health Risk |
Pathogenic |
Microphthalmia, Microphthalmia |
| RS2041850053 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2041850171 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Neurodevelopmental abnormality |
| RS2041854606 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS2041856807 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2041898606 |
FRMPD4
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 104 |
| RS2041899970 |
FRMPD4
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 104 |
| RS2041910387 |
PSMD12
|
Health Risk |
Pathogenic |
— |
| RS2041937196 |
TRIP12
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS2041946364 |
PSMD12
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2041951083 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2041952899 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2041953300 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2041967070 |
ABCA7
|
Health Risk |
Likely pathogenic |
ABCA7-related disorder, ABCA7-related disorder |
| RS2041974262 |
PSMD12
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |